Myovant Sciences (NYSE:MYOV) has announced a collaboration with Pfizer Inc. (NYSE:PFE) for the development and commercialization of relugolix (ORGOVYX) in women’s health and oncology in North America. Pfizer to co-commercialize relugolix with Myovant Following the...
